Phase I Study and Clinical Pharmacological Evaluation of Daily Oral Etoposide Combined with Carboplatin in Patients with Lung Cancer

Twenty‐eight patients with inoperable or relapsed lung cancer were given a combination of oral etoposide, administered once a day at doses ranging from 40 to 60 mg/m(2)/day (d) for 21 consecutive days, and carboplatin, administered intravenously over 1 h at doses ranging from 300 to 400 mg/m(2) on d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohune, Terumasa, Fujiwara, Yasuhiro, Sumiyoshi, Hidetaka, Yamaoka, Naoki, Yamakido, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920854/
https://www.ncbi.nlm.nih.gov/pubmed/7790322
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03083.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920854/
https://www.ncbi.nlm.nih.gov/pubmed/7790322
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03083.x

Ejemplares similares